Thomas J. Salentine, Jr. Sells 651,454 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Thomas J. Salentine, Jr. sold 651,454 shares of the company’s stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the sale, the director now directly owns 1,939,817 shares in the company, valued at approximately $39,106,710.72. The trade was a 25.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Guardian Pharmacy Services Stock Performance

GRDN stock opened at $21.37 on Friday. The company’s 50 day moving average price is $23.14 and its 200 day moving average price is $22.00. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. Equities analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

GRDN has been the subject of several research reports. Raymond James set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an “outperform” rating in a research note on Wednesday, May 14th. Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, Truist Financial reissued a “buy” rating and set a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently modified their holdings of the company. Envestnet Asset Management Inc. raised its stake in Guardian Pharmacy Services by 4.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company’s stock valued at $243,000 after buying an additional 564 shares in the last quarter. LPL Financial LLC boosted its position in shares of Guardian Pharmacy Services by 4.8% during the 4th quarter. LPL Financial LLC now owns 17,679 shares of the company’s stock worth $358,000 after acquiring an additional 807 shares in the last quarter. GAMMA Investing LLC purchased a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at about $170,000. Lazard Asset Management LLC increased its holdings in shares of Guardian Pharmacy Services by 0.5% in the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company’s stock valued at $3,865,000 after acquiring an additional 860 shares during the last quarter. Finally, R Squared Ltd acquired a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $30,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.